SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants by Jones, M, Cunningham, M, Wing, P, Desilva, S, Challa, R, Sheri, A, Padmanabhan, S, Iyer, R, Korba, B, Afdhal, N, Foster, G